Paper Details

  1. Home
  2. Paper Details

[Clinical evaluation of cefixime in pediatric respiratory tract infections].

Author: IwaiN, KasaiK, MakiT, MatsuiY, NakamuraH, OzakiT, TanedaY, TauchiN, YamaguchiH

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Cefixime (CFIX) was highly effective and well-tolerated in treating pediatric respiratory tract infections, particularly those caused by Haemophilus influenzae. Clinical efficacy was high, with excellent bacteriological eradication rates observed.
Paper Details　
Original Abstract of the Article :
Cefixime (CFIX) was evaluated clinically in pediatric respiratory tract infections, particularly those caused by Haemophilus influenzae: 1. The total number of children in this study treated with CFIX was 232, out of which 215 cases were evaluated for clinical efficacy and 224 cases were investigate...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/2041146

データ提供：米国国立医学図書館（NLM）

Cefixime: A Valuable Weapon Against Pediatric Respiratory Infections

The field of pediatrics is a constantly evolving desert, with new challenges and discoveries emerging regularly. This study investigates the efficacy and safety of cefixime, a commonly used antibiotic, in treating pediatric respiratory tract infections, particularly those caused by Haemophilus influenzae. The researchers conducted a clinical trial involving 232 children, evaluating the effectiveness and safety of cefixime in various respiratory infections. Their findings demonstrate that cefixime achieved a high efficacy rate in treating a wide range of respiratory infections, including those caused by Haemophilus influenzae, Streptococcus pyogenes, and Streptococcus pneumoniae. This study highlights the potential of cefixime as a valuable tool in managing pediatric respiratory infections.

Cefixime: A Reliable Ally in Pediatric Respiratory Care

This study confirms the effectiveness and safety of cefixime in treating a wide range of pediatric respiratory infections, including those caused by Haemophilus influenzae, Streptococcus pyogenes, and Streptococcus pneumoniae. Cefixime offers a valuable and reliable option for managing these infections in children, contributing to their overall health and well-being.

Navigating the Desert of Pediatric Infections

The desert of pediatric infections can be a challenging landscape, with young patients often susceptible to a variety of illnesses. This study highlights the potential of cefixime as a valuable tool in managing pediatric respiratory infections. By understanding the effectiveness and safety of this antibiotic, we can navigate this desert with greater confidence and provide effective care for our young patients.

Dr.Camel's Conclusion

This study confirms the efficacy and safety of cefixime in treating a wide range of pediatric respiratory infections, including those caused by Haemophilus influenzae, Streptococcus pyogenes, and Streptococcus pneumoniae. Cefixime offers a valuable and reliable option for managing these infections, contributing to the overall health and well-being of our young patients.

Date :
  1. Date Completed 1991-07-08
  2. Date Revised 2020-12-09
Further Info :

Pubmed ID

2041146

DOI: Digital Object Identifier

2041146

Related Literature

Article Analysis
・Side Effects of cefixime
SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.